​

Cabaletta Bio Ownership | Who Owns Cabaletta Bio?

OverviewForecastRevenueFinancialsChart

Cabaletta Bio Ownership Summary

Cabaletta Bio is owned by 26.68% institutional investors, 1.57% insiders, and 71.74% retail investors. Bain capital life sciences investors is the largest institutional shareholder, holding 15.64% of CABA shares. Jennison Health Sciences Equity is the top mutual fund, with 3.91% of its assets in Cabaletta Bio shares.

CABA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCabaletta Bio26.68%1.57%71.74%
SectorHealthcare Stocks 42.50%10.81%46.69%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bain capital life sciences investors9.68M15.64%$22.64M
Adage capital partners gp8.83M14.27%$20.66M
Jennison associates8.50M13.73%$19.88M
T. rowe price investment management8.36M13.51%$19.57M
Blackrock4.76M9.65%$35.58M
Cormorant asset management, lp5.00M8.08%$11.70M
Vanguard group4.19M6.77%$9.81M
Woodline partners lp2.14M3.45%$5.00M
Heights capital management2.08M3.37%$4.88M
Blackrock funding, inc. /de1.62M2.62%$3.79M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Superstring capital management lp1.54M3.56%$3.61M
Bain capital life sciences investors9.68M1.50%$22.64M
Heights capital management2.08M1.34%$4.88M
Cormorant asset management, lp5.00M0.81%$11.70M
Opaleye management808.88K0.27%$1.89M
Almitas capital387.49K0.21%$906.73K
Burkehill global management, lp700.00K0.09%$1.64M
Atika capital management1.00K0.07%$748.00K
Xtx topco284.30K0.03%$665.26K
Adage capital partners gp8.83M0.03%$20.66M

Top Buyers

HolderShares% AssetsChange
Jennison associates8.50M0.01%2.48M
T. rowe price investment management8.36M0.01%1.57M
Renaissance1.34M0.00%1.21M
Marshall wace, llp1.33M0.00%1.14M
Woodline partners lp2.14M0.02%916.88K

Top Sellers

HolderShares% AssetsChange
Alyeska investment group1.30M0.01%-3.50M
Alkeon capital management---2.62M
Jefferies financial group47.50K0.00%-1.95M
Anson funds management lp---1.82M
Vr adviser---1.56M

New Positions

HolderShares% AssetsChangeValue
Opaleye management808.88K0.27%808.88K$1.89M
Qube research89.16K0.00%89.16K$208.63K
Quadrature capital42.91K0.00%42.91K$100.41K
Susquehanna portfolio strategies33.94K0.00%33.94K$79.41K
Nomura23.06K0.00%23.06K$172.47K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-7.00
Gamma investing-12.00
True wealth design-17.00
Quantbot technologies lp-19.00
Eversource wealth advisors-41.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202522-75.56%16,510,649-77.31%260.19%12-76.47%7-73.08%
Jun 30, 202589-6.32%72,682,277102.25%1172.23%5019.05%27-20.59%
Mar 31, 202596-12.73%36,286,368-5.67%731.19%42-35.38%3545.83%
Dec 31, 202436-70.25%10,990,024-77.13%220.23%22-66.15%7-78.79%
Sep 30, 2024120-15.49%48,049,085-5.40%980.93%65-7.14%33-32.65%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Jennison Health Sciences Equity3.52M3.91%2.14M
PGIM Jennison Health Sciences Z3.52M3.85%-
T. Rowe Price Small-Cap Value3.31M3.62%-251.61K
Vanguard Total Stock Mkt Idx Inv2.56M2.80%-56.45K
Vanguard US Total Market Shares ETF1.40M2.76%-
Jennison SMid Cap Core Equity1.29M2.63%-
PGIM Jennison Small Company A1.29M2.63%-
T. Rowe Price U.S. SC Value Eq Tr-D2.10M2.33%1.04M
iShares Russell 2000 ETF1.17M2.31%-
Alger Small Cap Focus Composite1.08M2.12%-561.71K

Recent Insider Transactions

DateNameRoleActivityValue
Jan 19, 2024Binder Gwendolyn See RemarksSell$14.23K
Jan 19, 2024Binder Gwendolyn See RemarksSell$201.21K
Dec 19, 2023Binder Gwendolyn See RemarksSell$171.20K
Dec 19, 2023Binder Gwendolyn See RemarksSell$69.59K
Nov 20, 2023Binder Gwendolyn See RemarksSell$61.61K

Insider Transactions Trends

DateBuySell
2025 Q4--
2025 Q2--
2025 Q1--
2024 Q2--
2024 Q1-2

CABA Ownership FAQ

Who Owns Cabaletta Bio?

Cabaletta Bio shareholders are primarily institutional investors at 26.68%, followed by 1.57% insiders and 71.75% retail investors. The average institutional ownership in Cabaletta Bio's industry, Biotech Stocks , is 45.24%, which Cabaletta Bio falls below.

Who owns the most shares of Cabaletta Bio?

Cabaletta Bio’s largest shareholders are Bain capital life sciences investors (9.68M shares, 15.64%), Adage capital partners gp (8.83M shares, 14.27%), and Jennison associates (8.5M shares, 13.73%). Together, they hold 43.64% of Cabaletta Bio’s total shares outstanding.

Does Blackrock own Cabaletta Bio?

Yes, BlackRock owns 9.65% of Cabaletta Bio, totaling 4.76M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 35.58M$. In the last quarter, BlackRock increased its holdings by 699.11K shares, a 17.23% change.

Who is Cabaletta Bio’s biggest shareholder by percentage of total assets invested?

Superstring capital management lp is Cabaletta Bio’s biggest shareholder by percentage of total assets invested, with 3.56% of its assets in 1.54M Cabaletta Bio shares, valued at 3.61M$.

Who is the top mutual fund holder of Cabaletta Bio shares?

Jennison Health Sciences Equity is the top mutual fund holder of Cabaletta Bio shares, with 3.91% of its total shares outstanding invested in 3.52M Cabaletta Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools